Australia markets open in 8 hours 7 minutes

Twist Bioscience Corp (0ME.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
26.96+0.98 (+3.79%)
At close: 09:59PM CET
Full screen
Previous close25.98
Open26.11
Bid27.02 x 280000
Ask27.33 x 190000
Day's range26.11 - 26.96
52-week range23.43 - 79.72
Volume0
Avg. volume12
Market capN/A
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings date02 Feb 2023 - 06 Feb 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Twist Bioscience to Present at 5th Annual Evercore ISI HealthCONx Conference

    SOUTH SAN FRANCISCO, Calif., November 23, 2022--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, and Jim Thorburn, CFO of Twist Bioscience, will host a fireside chat and one-on-one meetings at the 5th Annual Evercore ISI HealthCONx Conference on Wednesday, November 30th at 4:20 p.m. Eastern Time.

  • Simply Wall St.

    Twist Bioscience Full Year 2022 Earnings: EPS Beats Expectations

    Twist Bioscience ( NASDAQ:TWST ) Full Year 2022 Results Key Financial Results Revenue: US$203.6m (up 54% from FY 2021...

  • Zacks

    Twist Bioscience (TWST) Reports Q4 Loss, Tops Revenue Estimates

    Twist Bioscience (TWST) delivered earnings and revenue surprises of 28.91% and 0.56%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?